Next Article in Journal
Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers
Previous Article in Journal
Biliary Tract Cancer: Current Medical Treatment Strategies
Open AccessArticle

Tumorigenic and Metastatic Role of CD44−/low/CD24−/low Cells in Luminal Breast Cancer

Taiwan International Graduate Program in Molecular Medicine, National Yang–Ming University and Academia Sinica, Taipei 115, Taiwan
Institute of Biomedical Sciences, Taipei 115, Taiwan
Drug Development Center, Institute of New Drug Development, China Medical University, Taichung 404, Taiwan
Graduate Institute of Environmental Science, China Medical University, Taichung 404, Taiwan
Author to whom correspondence should be addressed.
Cancers 2020, 12(5), 1239;
Received: 3 April 2020 / Revised: 1 May 2020 / Accepted: 11 May 2020 / Published: 14 May 2020
Cells with high CD44 but low CD24 expression (CD44high/CD24−/low) and high aldehyde dehydrogenase activity (ALDHbr) are widely considered to be drivers of metastasis, therapy resistance and tumor recurrence in breast cancer. However, the role of the CD44high/CD24−/low and ALDHbr phenotypes in identifying tumorigenic cells in breast cancer remains controversial due to the discrepancy in their distribution and tumorigenic potential in intrinsic breast cancer subtypes. In this study, we analyzed the cells expressing these markers in six different breast cancer cell lines representing major breast cancer subtypes (T47D, MCF-7, BT-474, AU-565, Hs578T and MDA-MB-231). CD44high/CD24−/low, ALDHbr and CD44−/low/CD24−/low cell populations were isolated by flow cytometry and analyzed for hallmark stem cell characteristics of differentiation, migration, invasiveness and metastasis using in vitro and in vivo techniques. Our results demonstrate that the CD44−/low/CD24−/low cell population, which is enriched in luminal cell lines (T47D, MCF-7 and BT-474), possesses metastatic and tumorigenic properties. We also show that, contrary to previous claims, the expression of the ALDH1 isoform ALDH1A1 does not affect the tumorigenic potential of cell lines with high ALDH activity (BT-474 and AU-565). Further transcriptomic and clinical studies are needed to determine the potential of these markers as early diagnostic tools and treatment targets. View Full-Text
Keywords: breast cancer; ALDH1A1; CD44; CD24; metastasis, ALDH breast cancer; ALDH1A1; CD44; CD24; metastasis, ALDH
Show Figures

Figure 1

MDPI and ACS Style

Vikram, R.; Chou, W.C.; Hung, S.-C.; Shen, C.-Y. Tumorigenic and Metastatic Role of CD44−/low/CD24−/low Cells in Luminal Breast Cancer. Cancers 2020, 12, 1239.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop